Manufacturer of Controlled Substances; Notice of Application, 393 [05-69]

Download as PDF Federal Register / Vol. 70, No. 2 / Tuesday, January 4, 2005 / Notices of Liaison and Policy (ODLR) and must be filed no later than March 7, 2005. Dated: December 21, 2004. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–70 Filed 1–3–05; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on November 16, 2004, Organichem Corporation, 33 Riverside Avenue, Rensselaer, New York 12144, made application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of Hydrocodone (9193) and Fentanyl (9180), a basic class of controlled substances in Schedule II. The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: Federal Register Representative, Office of Liaison and Policy (ODLR) and must be filed no later than March 7, 2005. Dated: December 21, 2004. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–69 Filed 1–3–05; 8:45 am] Enforcement Administration (DEA) for registration as a bulk manufacturer of Codeine (9041), a basic class of controlled substance listed in Schedule II. The company plans to manufacture small quantities of the listed controlled substance for use in drug abuse detection kits. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative, Office of Liaison and Policy (ODLR) and must be filed no later than March 7, 2005. Dated: December 21, 2004. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–67 Filed 1–3–05; 8:45 am] Pursuant to 21 CFR 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 2, 2004, Organix Inc., 240 Salem Street, Woburn, Massachusetts 01801, made application by renewal to the Drug VerDate jul<14>2003 18:02 Jan 03, 2005 Jkt 205001 BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Importer of Controlled Substances; Notice of Registration Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated July 21, 2004, and published in the Federal Register on August 10, 2004, (69 FR 48525), Syva Company, Dade Behring Inc., Regulatory Affairs Dept. 1–310, 20400 Mariani Avenue, Cupertino, California 95014, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed below, and by letter dated July 6, 2004, to modify its name to Dade Behring, Inc. Schedule Tetrahydrocannabionols (7370) ... Ecgonine (9180) ........................... Morphine (9300) ........................... Manufacturer of Controlled Substances; Notice of Application Dated: December 21, 2004. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–62 Filed 1–3–05; 8:45 am] Drug Enforcement Administration Drug Drug Enforcement Administration Company, Dade Behring Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Syva Company, Dade Behring Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. BILLING CODE 4410–09–P BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE 393 I II II The company plans to produce the listed controlled substances in bulk to be used in the manufacture of reagents and drug calibrator/controls for DEA exempt products. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Syva PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 By Notice dated September 16, 2004 and published in the Federal Register on September 30, 2004, (69 FR 58548), Tocris Cookson, Inc., 16144 Westwoods Business Park, Ellisville, Missouri 63021–4500, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Tetrahydrocannabinols (7370), a basic class of controlled substance listed in Schedule I. The company plans to import small quantities of the listed substance for research purposes. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Tocris Cookson, Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Tocris Cookson, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the E:\FR\FM\04JAN1.SGM 04JAN1

Agencies

[Federal Register Volume 70, Number 2 (Tuesday, January 4, 2005)]
[Notices]
[Page 393]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-69]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on November 16, 2004, Organichem 
Corporation, 33 Riverside Avenue, Rensselaer, New York 12144, made 
application by letter to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of Hydrocodone (9193) and Fentanyl 
(9180), a basic class of controlled substances in Schedule II.
    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Federal Register Representative, 
Office of Liaison and Policy (ODLR) and must be filed no later than 
March 7, 2005.

    Dated: December 21, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-69 Filed 1-3-05; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.